Synonyms: compound C9 [WO2020081879A2] | PTC-857 | PTC857
Compound class:
Synthetic organic
Comment: Utreloxastat (PTC-857) is described as a 15-lipoxygenase inhibitor in its INN record. It was developed for potential to treat α-synucleinopathies, tauopathies, ALS and other brain injuries/insults [1].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione |
International Nonproprietary Names ![]() |
|
INN number | INN |
11733 | utreloxastat |
Synonyms ![]() |
compound C9 [WO2020081879A2] | PTC-857 | PTC857 |
Database Links ![]() |
|
CAS Registry No. | 1213269-96-5 (source: WHO INN record) |
GtoPdb PubChem SID | 491300042 |
PubChem CID | 46174641 |
Search Google for chemical match using the InChIKey | IJWAQTHZBDBIID-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | IJWAQTHZBDBIID |
Search PubMed clinical trials | utreloxastat |
Search PubMed titles | utreloxastat |
Search PubMed titles/abstracts | utreloxastat |
UniChem Compound Search for chemical match using the InChIKey | IJWAQTHZBDBIID-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | IJWAQTHZBDBIID-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Utreloxastat (links to external site)
Cat. No. HY-132845 |